Two Breakthrough Treatments in the Fight Against Cancer SCOTTSDALE, Ariz. , Nov. 19, 2024 /PRNewswire/ -- Envita Medical Center's Genetically Targeted Fractionated Chemotherapy (GTFC) and Chemo Immuno Precision Injection (CIPI) are revolutionizing cancer treatment and offering new hope to patients, even those facing advanced stages of the illness.
Dr. John Oertle , Chief Medical Director at Envita Medical Centers , emphasizes the significance of these groundbreaking therapies: "With GTFC and CIPI, we provide patients with exceptional precision to target cancer right at its source, while also activating the immune system to promote lasting recovery throughout the body—transforming cancer care for improved outcomes and minimizing side effects." At Envita Medical Centers , a leading integrative Center of Excellence for Precision Oncology, cancer patients can explore more tailored treatment options and the opportunity to embrace life again, even after being dismissed by conventional cancer treatment facilities.
Since cancer stems from genetic mutations that differ from individual to individual, personalized care is essential for effectively addressing this illness. Tammy Morrow experienced the tough reality of standardized chemotherapy, losing both her hair and her energy. She recalls how everything shifted when she arrived at Envita Medical Centers .
"After being diagnosed with Stage 4 metastatic breast cancer, I felt like my chances for survival were very bleak," Tammy explai.
